CTGF has been recently reported to play a role in tumorigenesis and its expression is elevated in various tumors including acute lymphoblastic leukemias [60], esophageal squamous cell carcinomas [61], pancreatic cancers [61], [62] and prostate cancer [63]. Here, CCN2 is linked to prostate cancer.